Rosetta Genomics
Edit Page
Report
Scan day: 17 February 2014 UTC
11
Virus safety - good
Description: Israel-based microRNA genomics company, develops bioinformatic tools for miRNA gene detection approach.
At Rosetta Genomics we discover, develop and commercialize next generation diagnostic tests for personalized medicine. The people of Rosetta are deeply committed to helping identify and treat disease. There is great passion for accuracy and finding the right solutions — it’s not about an answer, it’s about the right answer. Rosetta associates believe in each other and have great faith in what they are doing to help patients.
Size: 434 chars
Contact Information
Email: —
Phone&Fax: —
Address: —
Extended: —
WEBSITE Info
Page title: | Rosetta Genomics: Home |
Keywords: | technologies, diagnostic, tissue, proprietary technologies, health, genomics, molecular, biomarkers, rosetta genomics, microrna-based, micrornas, genes, highly sensitive tissue, biomarkers, pathological, rosetta, molecular diagnostics, genomics' proprietary technologies, ffpe samples, micrornas, tests, molecular, cancer, CUP, cancer of unknown primary, unknown cancer, differential diagnosis, occult primary, metastatic disease, Lab, CAP-accredited, CLIA-certified |
Description: | Rosetta Genomics is a leading developer of microRNA-based diagnostic tests and therapeutic tools. MicroRNAs (miRNAs) are a recently discovered group of short (21–23 nucleotides in length), RNA sequences which regulate the expression of genes. MicroRNAs have also been shown to have varying expression levels across various pathological conditions, and offer a new class of highly sensitive and tissue specific biomarkers. MicroRNA-based diagnostics may offer physicians and patients an objective tool to accurately identify cancer, predict outcomes and help guide treatment. |
IP-address: | 216.248.195.58 |
WHOIS Info
NS | Name Server: NS1.BEZEQINT.NET Name Server: NS2.BEZEQINT.NET Name Server: NS3.BEZEQINT.NET |
WHOIS | Status: clientDeleteProhibited Status: clientTransferProhibited |
Date | Creation Date: 28-dec-1999 Expiration Date: 28-dec-2017 |